Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
3.330
-0.090 (-2.63%)
Aug 1, 2025, 11:03 AM - Market open
Exscientia Stock Forecast
Stock Price Forecast
The 4 analysts that cover Exscientia stock have a consensus rating of "Strong Buy" and an average price target of $8.38, which forecasts a 151.65% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $13.
Price Target: $8.38 (+151.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exscientia stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +80.18% | Jul 15, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +110.21% | Apr 22, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $6.5 | Strong Buy | Maintains | $7 → $6.5 | +95.20% | Feb 13, 2025 |
Lake Street | Lake Street | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +140.24% | Feb 7, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9.5 → $7 | Strong Buy | Maintains | $9.5 → $7 | +110.21% | Feb 7, 2025 |
Financial Forecast
Revenue This Year
379.80M
from 464.83M
Decreased by -18.29%
Revenue Next Year
407.52M
from 379.80M
Increased by 7.30%
EPS This Year
-0.07
from 0.05
EPS Next Year
0.21
from -0.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | 400.4M | 430.5M | 491.2M | |||
Avg | 379.8M | 407.5M | 477.2M | |||
Low | 359.7M | 384.3M | 458.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | -13.9% | 13.3% | 20.5% | |||
Avg | -18.3% | 7.3% | 17.1% | |||
Low | -22.6% | 1.2% | 12.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | -0.04 | 0.40 | 0.43 | |||
Avg | -0.07 | 0.21 | 0.42 | |||
Low | -0.09 | 0.10 | 0.40 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|---|
High | - | - | 105.9% | |||
Avg | - | - | 100.0% | |||
Low | - | - | 92.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.